NEULANDLAB — Neuland Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹214.17bn
- IN₹213.59bn
- IN₹20.23bn
Annual cashflow statement for Neuland Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 822 | 2,157 | 4,014 | 3,463 | 4,890 |
| Depreciation | |||||
| Non-Cash Items | 173 | 233 | 3.81 | -780 | 109 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -881 | -546 | -2,003 | -165 | -2,450 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 604 | 2,372 | 2,612 | 3,174 | 3,467 |
| Capital Expenditures | -977 | -661 | -1,437 | -2,065 | -3,971 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 21.7 | 46.3 | -60.2 | -917 | -266 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -955 | -615 | -1,497 | -2,982 | -4,237 |
| Financing Cash Flow Items | -136 | -132 | -141 | -83.8 | -240 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 377 | -1,358 | -693 | 250 | 210 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26.6 | 403 | 422 | 444 | -553 |